{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:51:33Z","timestamp":1792039893892,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.chest.2018.01.024","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T03:20:54Z","timestamp":1517541654000},"page":"888-921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":180,"title":["Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease"],"prefix":"10.1016","volume":"153","author":[{"given":"Roland","family":"Diel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Nienhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix C.","family":"Ringshausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus F.","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Loddenkemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2018.01.024_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijid.2016.03.006","article-title":"Update on pulmonary disease due to non-tuberculous mycobacteria","volume":"45","author":"Stout","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.chest.2018.01.024_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"and the ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2018.01.024_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2334-13-231","article-title":"Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005-2011","volume":"13","author":"Ringshausen","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.chest.2018.01.024_bib5","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1164\/rccm.201612-2479OC","article-title":"Whole-exome sequencing identifies the 6q12-q16 linkage region and a candidate gene, TTK, for pulmonary nontuberculous mycobacterial disease","volume":"196","author":"Chen","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1513\/AnnalsATS.201304-085OC","article-title":"Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease","volume":"11","author":"Adjemian","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.chest.2018.01.024_bib7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/13993003.00033-2016","article-title":"Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease","volume":"48","author":"Marras","year":"2016","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0033-1333567","article-title":"Update on the epidemiology of pulmonary nontuberculous mycobacterial infections","volume":"34","author":"Kendall","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2018.01.024_bib9","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","article-title":"and the Nontuberculous Mycobacteria Network European Trials Group. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4046\/trd.2014.77.1.1","article-title":"Diagnosis of pulmonary tuberculosis and nontuberculous mycobacterial lung disease in Korea","volume":"77","author":"Kwon","year":"2014","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"3","key":"10.1016\/j.chest.2018.01.024_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5588\/ijtld.11.0148","article-title":"Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease","volume":"16","author":"Ito","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib12","doi-asserted-by":"crossref","first-page":"e000242","DOI":"10.1136\/bmjresp-2017-000242","article-title":"British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"4","author":"Haworth","year":"2017","journal-title":"BMJ Open Respir Res"},{"issue":"2","key":"10.1016\/j.chest.2018.01.024_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1378\/chest.126.2.566","article-title":"Mycobacterium avium complex pulmonary disease in patients without HIV infection","volume":"126","author":"Field","year":"2004","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2018.01.024_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10096-013-1962-1","article-title":"Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis","volume":"33","author":"Xu","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.chest.2018.01.024_bib15","doi-asserted-by":"crossref","unstructured":"Kwak N, Park J, Kim E, Lee CH, Han SK, Yim JJ. Treatment outcomes of Mycobacterium avium complex lung disease: a systematic review and meta-analysis [published online ahead of print June 3, 2017]. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/cix517.","DOI":"10.1093\/cid\/cix517"},{"issue":"3","key":"10.1016\/j.chest.2018.01.024_bib16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/CMR.05030-11","article-title":"Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria","volume":"25","author":"Brown-Elliott","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"14","key":"10.1016\/j.chest.2018.01.024_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clinmicnews.2012.06.004","article-title":"Enhancement of conventional phenotypic methods with molecular-based methods for the more definitive identification of nontuberculous mycobacteria","volume":"34","author":"Brown-Elliott","year":"2012","journal-title":"Clin Microbiol Newsl"},{"key":"10.1016\/j.chest.2018.01.024_bib18","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.chest.2018.01.024_bib19","unstructured":"Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011). http:\/\/training.cochrane.org\/handbook. Accessed February 27, 2018."},{"key":"10.1016\/j.chest.2018.01.024_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2466-7-2","article-title":"Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series","volume":"7","author":"Davis","year":"2007","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1016\/j.chest.2018.01.024_bib21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1378\/chest.107.4.1035","article-title":"Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS: Clarithromycin Study Group of France","volume":"107","author":"Dautzenberg","year":"1995","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2018.01.024_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/resp.12676","article-title":"Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease","volume":"21","author":"Ellender","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.chest.2018.01.024_bib23","doi-asserted-by":"crossref","first-page":"e104411","DOI":"10.1371\/journal.pone.0104411","article-title":"Pilot quasi-randomized controlled study of herbal medicine Hochuekkito as an adjunct to conventional treatment for progressed pulmonary Mycobacterium avium complex disease","volume":"9","author":"Enomoto","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.chest.2018.01.024_bib24","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.124.4.1482","article-title":"Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine","volume":"124","author":"Field","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2018.01.024_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10156-011-0303-5","article-title":"The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease","volume":"18","author":"Fujita","year":"2012","journal-title":"J\u00a0Infect Chemother"},{"issue":"5","key":"10.1016\/j.chest.2018.01.024_bib26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/clinids\/23.5.983","article-title":"Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus","volume":"23","author":"Griffith","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1086\/515597","article-title":"Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus negative patients","volume":"178","author":"Griffith","year":"1998","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.chest.2018.01.024_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1086\/313644","article-title":"Early results (at 6\u00a0months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex","volume":"30","author":"Griffith","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.chest.2018.01.024_bib29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/320512","article-title":"Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease","volume":"32","author":"Griffith","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.chest.2018.01.024_bib30","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1378\/chest.08-2567","article-title":"Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease","volume":"136","author":"Hasegawa","year":"2009","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2018.01.024_bib31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1378\/chest.115.4.1033","article-title":"Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations","volume":"115","author":"Huang","year":"1999","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2018.01.024_bib32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1378\/chest.15-0543","article-title":"Long term follow up of Mycobacterium avium complex lung disease in patients treated with regimens including clofazimine and\/or rifampin","volume":"149","author":"Jarand","year":"2016","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.chest.2018.01.024_bib33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/thx.2007.087999","article-title":"Clarithromycin vs\u00a0ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy","volume":"63","author":"Jenkins","year":"2008","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.201408-1545OC","article-title":"Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease","volume":"191","author":"Jeong","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2018.01.024_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12879-016-1384-7","article-title":"Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease","volume":"16","author":"Kadota","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.chest.2018.01.024_bib36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2169\/internalmedicine.42.670","article-title":"The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease","volume":"42","author":"Kobashi","year":"2003","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.chest.2018.01.024_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10156-006-0457-8","article-title":"Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates","volume":"12","author":"Kobashi","year":"2006","journal-title":"J\u00a0Infect Chemother"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.rmed.2006.04.002","article-title":"A\u00a0double-blind randomized study of amino-glycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease","volume":"101","author":"Kobashi","year":"2007","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2018.01.024_bib39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000095674","article-title":"The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan: including a follow-up study","volume":"74","author":"Kobashi","year":"2007","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.chest.2018.01.024_bib40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10156-011-0351-x","article-title":"Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period","volume":"18","author":"Kobashi","year":"2012","journal-title":"J\u00a0Infect Chemother"},{"issue":"5","key":"10.1016\/j.chest.2018.01.024_bib41","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1128\/AAC.02281-12","article-title":"Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen","volume":"57","author":"Koh","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.chest.2018.01.024_bib42","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1128\/AAC.00648-15","article-title":"Response to switch from intermittent therapy to daily therapy for refractory nodular bronchiectatic Mycobacterium avium complex lung disease","volume":"59","author":"Koh","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.chest.2018.01.024_bib43","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1164\/rccm.200509-1531OC","article-title":"Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease","volume":"173","author":"Lam","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib44","first-page":"138","article-title":"Short course antimicrobial therapy for adult patients with Mycobacterium avium complex (MAC) pulmonary infection: a pilot study","volume":"4","author":"Leventhal","year":"2013","journal-title":"J\u00a0Mycobac Dis"},{"key":"10.1016\/j.chest.2018.01.024_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2334-8-17","article-title":"and the MACGAM Study Group. Adjuvant interferon gamma in patients with pulmonary atypical mycobacteriosis: a randomized, double-blind, placebo-controlled study","volume":"8","author":"Milan\u00e9s-Virelles","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1513\/AnnalsATS.201308-266OC","article-title":"Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease: a preliminary study","volume":"11","author":"Miwa","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.chest.2018.01.024_bib47","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1086\/589250","article-title":"Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection","volume":"47","author":"Murray","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.201307-231OC","article-title":"Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease","volume":"11","author":"Olivier","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.chest.2018.01.024_bib49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1378\/chest.14-2764","article-title":"Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease","volume":"148","author":"Philley","year":"2015","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chest.2018.01.024_bib50","first-page":"462","article-title":"Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome: GETIM\u2014Groupe d'Etude et de Traitement des Infections \u00e0 Mycobact\u00e9ries","volume":"2","author":"Roussel","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.chest.2018.01.024_bib51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1010-7940(01)01122-8","article-title":"Surgery for Mycobacterium avium complex lung disease in the clarithromycin era","volume":"21","author":"Shiraishi","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.chest.2018.01.024_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.athoracsur.2013.03.008","article-title":"Adjuvant surgical treatment of nontuberculous mycobacterial lung disease","volume":"96","author":"Shiraishi","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.chest.2018.01.024_bib53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40780-015-0025-4","article-title":"Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease","volume":"1","author":"Shimomura","year":"2015","journal-title":"J\u00a0Pharm Health Care Sci"},{"issue":"6","key":"10.1016\/j.chest.2018.01.024_bib54","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3349\/ymj.2010.51.6.888","article-title":"Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease","volume":"51","author":"Sim","year":"2010","journal-title":"Yonsei Med J"},{"issue":"3","key":"10.1016\/j.chest.2018.01.024_bib55","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1164\/ajrccm.160.3.9811086","article-title":"Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease","volume":"160","author":"Tanaka","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2018.01.024_bib56","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.athoracsur.2006.01.031","article-title":"Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones","volume":"81","author":"Watanabe","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.chest.2018.01.024_bib57","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/ajrccm.149.5.8173775","article-title":"Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease","volume":"149","author":"Wallace","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"6 pt 1","key":"10.1016\/j.chest.2018.01.024_bib58","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1164\/ajrccm.153.6.8665032","article-title":"Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients","volume":"153","author":"Wallace","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2018.01.024_bib59","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.13-2538","article-title":"Macrolide\/azalide therapy for nodular\/bronchiectatic Mycobacterium avium complex lung disease","volume":"146","author":"Wallace","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2018.01.024_bib60","first-page":"342","article-title":"Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease","volume":"40","author":"Ye","year":"2007","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.chest.2018.01.024_bib61","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.201604-0700OC","article-title":"Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease","volume":"195","author":"Olivier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2018.01.024_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12879-016-1521-3","article-title":"Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012","volume":"16","author":"Shah","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.chest.2018.01.024_bib63","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/1471-2458-10-612","article-title":"Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006","volume":"10","author":"Moore","year":"2010","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.chest.2018.01.024_bib64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1183\/13993003.02109-2016","article-title":"Burden of non-tuberculous mycobacterial pulmonary disease in Germany","volume":"49","author":"Diel","year":"2017","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.chest.2018.01.024_bib65","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/rccm.201508-1515LE","article-title":"Reply: cure not possible, by definition","volume":"192","author":"Griffith","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2018.01.024_bib66","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","article-title":"Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease","volume":"185","author":"Hayashi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.chest.2018.01.024_bib67","doi-asserted-by":"crossref","first-page":"e008058","DOI":"10.1136\/bmjopen-2015-008058","article-title":"Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular\/bronchiectatic Mycobacterium avium complex lung disease","volume":"5","author":"Gochi","year":"2015","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.chest.2018.01.024_bib68","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0041-111494","article-title":"Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of non-tuberculous mycobacterioses","volume":"70","author":"Schoenfeld","year":"2016","journal-title":"Pneumologie"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218301636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218301636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:00:54Z","timestamp":1757923254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369218301636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0012369218301636"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2018.01.024","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732615233.793565553","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2018.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}